title: Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
authors.forename: Constantine G
authors.initials: CG
authors.lastname: Lyketsos
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Colenda
authors.forename: Cornelia
authors.initials: C
authors.lastname: Beck
authors.forename: Karen
authors.initials: K
authors.lastname: Blank
authors.forename: Murali P
authors.initials: MP
authors.lastname: Doraiswamy
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Kalunian
authors.forename: Kristine
authors.initials: K
authors.lastname: Yaffe
mesh_terms: D000368:Aged; D000470:Alkaloids; D000544:Alzheimer Disease / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D001921:Brain / Q000473:pathology; D017028:Caregivers / Q000193:education; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology*; D003704:Dementia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005702:Galantamine / Q000627:therapeutic use; D005852:Geriatric Psychiatry / Q000379:methods / Q000592:standards*; D006299:Health Services for the Aged / Q000592:standards*; D006801:Humans; D048448:Phenylcarbamates / Q000627:therapeutic use; D011368:Professional-Family Relations; D000068836:Rivastigmine; D012717:Sesquiterpenes / Q000627:therapeutic use; D013619:Tacrine / Q000627:therapeutic use; D014481:United States
chemical_list: D000470:Alkaloids; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D012717:Sesquiterpenes; C050426:huperzine A; D005702:Galantamine; D013619:Tacrine; D000068836:Rivastigmine